PP
GOSS icon

PDT Partners’s Gossamer Bio GOSS Stock Holding History

PDT Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,996
Closed -$204K – 737
2022
Q3 		$204K Sell
16,996
-52,732
-76% -$655K 0.03% 713
2022
Q2 		$584K Sell
69,728
-31,024
-31% -$240K 0.05% 560
2022
Q1 		$875K Buy
100,752
+13,570
+16% +$131K 0.08% 415
2021
Q4 		$986K Buy
87,182
+17,369
+25% +$206K 0.08% 360
2021
Q3 		$878K Sell
69,813
-27,887
-29% -$257K 0.06% 367
2021
Q2 		$793K Sell
97,700
-15,120
-13% -$131K 0.05% 413
2021
Q1 		$1.04M Sell
112,820
-4,149
-4% -$41.8K 0.08% 367
2020
Q4 		$1.13M Buy
116,969
+101,771
+670% +$1M 0.08% 305
2020
Q3 		$189K Sell
15,198
-2,633
-15% -$34.9K 0.01% 636
2020
Q2 		$232K Buy
+17,831
New +$224K 0.02% 573

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's GOSS Position: Q4 2022 in Review

PDT Partners sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 16,996 shares — an estimated $204K sold.

PDT Partners first reported a position in GOSS in Q2 2020 and held it in 10 quarters. The position peaked at $1.13M in Q4 2020. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • PDT Partners reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 16,996 Gossamer Bio shares in Q4 2022, an estimated $204K.
  • PDT Partners first reported a position in Gossamer Bio in Q2 2020 and held it in 10 quarters.
  • PDT Partners's Gossamer Bio position peaked at $1.13M in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.